BackCASI Pharmaceuticals Overview

CASI Pharmaceuticals Total Revenue

Revenue analysis for CASI.

Quarterly Revenue

$3.08M
↓ 60.54% YoY

As of Sep 2025

Annual Revenue (TTM)

$26.85M
↑ 26.2% YoY

Trailing 12 months ending Sep 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin